- All sections
- C - Chemistry; metallurgy
- C08B - Polysaccharides; derivatives thereof
- C08B 37/10 - Heparin; Derivatives thereof
Patent holdings for IPC class C08B 37/10
Total number of patents in this class: 169
10-year publication summary
|
6
|
4
|
11
|
5
|
6
|
3
|
5
|
3
|
4
|
4
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Agency for Science, Technology and Research | 3512 |
11 |
| Momenta Pharmaceuticals, Inc. | 302 |
11 |
| Laboratorios Farmaceuticos Rovi, S.A. | 233 |
8 |
| Sanofi | 3836 |
8 |
| Dilafor AB | 19 |
4 |
| Rensselaer Polytechnic Institute | 776 |
4 |
| Seikagaku Corporation | 192 |
4 |
| Suzhou Ronnsi Pharma Co., Ltd. | 6 |
4 |
| sanofi-aventis | 427 |
4 |
| Tsinghua University | 5426 |
3 |
| Cantex Pharmaceuticals, Inc. | 23 |
3 |
| Dilaforette AB | 3 |
3 |
| Fuso Pharmaceutical Industries, Ltd. | 136 |
3 |
| Shandong University | 886 |
3 |
| University of Miyazaki | 133 |
3 |
| The University of North Carolina at Chapel Hill | 1928 |
3 |
| Ajinomoto Co., Inc. | 2337 |
2 |
| The Board of Regents of the University of Oklahoma | 567 |
2 |
| Cisen Pharmaceutical Co., Ltd. | 24 |
2 |
| Glytech, Inc. | 67 |
2 |
| Other owners | 82 |